Rowland Carmichael Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$322K Hold
1,908
0.1% 213
2020
Q3
$282K Hold
1,908
0.11% 203
2020
Q2
$313K Hold
1,908
0.13% 184
2020
Q1
$265K Hold
1,908
0.13% 188
2019
Q4
$251K Hold
1,908
0.09% 258
2019
Q3
$213K Buy
+1,908
New +$212K 0.07% 270
2019
Q2
Sell
-1,800
Closed -$234K 339
2019
Q1
$234K Hold
1,800
0.09% 230
2018
Q4
$208K Buy
+1,800
New +$201K 0.09% 217
2016
Q3
Sell
-2,537
Closed -$200K 297
2016
Q2
$200K Buy
+2,537
New +$191K 0.13% 215

Other funds holding LLY

Rowland Carmichael Advisors's LLY Position: Q4 2020 in Review

Rowland Carmichael Advisors held its Eli Lilly (LLY) position steady in Q4 2020 at 1,908 shares worth $322K. The position accounts for 0.1% of the portfolio, ranked #213.

Rowland Carmichael Advisors first reported a position in LLY in Q2 2016 and has held it in 9 quarters since. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Rowland Carmichael Advisors held 1,908 shares of Eli Lilly worth $322K as of Q4 2020.
  • Rowland Carmichael Advisors left its Eli Lilly share count unchanged in Q4 2020.
  • Eli Lilly made up 0.1% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #213 holding.
  • Rowland Carmichael Advisors first reported a position in Eli Lilly in Q2 2016 and has held it in 9 quarters since.
  • 1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.